Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2025-12-26 @ 4:49 AM
Study NCT ID:
NCT00937560
Status:
COMPLETED
Last Update Posted:
2017-11-06
First Post:
2009-07-06
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2012-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-07-06
First Submit QC Date:
None
Study First Post Date:
2009-07-13
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-02-09
Results First Submit QC Date:
None
Results First Post Date:
2015-02-24
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-10-05
Last Update Post Date:
2017-11-06
Last Update Post Date Type:
ACTUAL